Evolution of pharmaceuticals using 3D and 4D printing

Intelligent Pharmacy Pub Date : 2024-12-01 Epub Date: 2024-05-25 DOI:10.1016/j.ipha.2024.05.008
Afiya Baig, Rohan Barse, Asawari Paryekar, Vijay Jagtap
{"title":"Evolution of pharmaceuticals using 3D and 4D printing","authors":"Afiya Baig,&nbsp;Rohan Barse,&nbsp;Asawari Paryekar,&nbsp;Vijay Jagtap","doi":"10.1016/j.ipha.2024.05.008","DOIUrl":null,"url":null,"abstract":"<div><div>This overview examines the latest developments and applications of 3D and 4D printing in the health care and pharmaceutical field. The technique of creating a 3D object from a 3D model in the required size and shape is known as 3D printing. Whereas, 4D printing is the establishment of intricate three-dimensional formations that can change form in response to various external inputs. Applying 3D printing technology 3D printing, the healthcare industry has produced significant strides toward a patient-centred approach. The future of biomedical science and patient-centered care could be completely transformed by 3D printing with further advancements in research and development. 3D, 4D Technology used in printing is one of the most advanced industrial technologies available worldwide. The 3D and 4D printing pharmaceutical enterprises have completed the shift from centralised to distributed systems for the purpose of creating dosage forms. The goal of the study is to support the research goal of determining the degree to which patient-specific treatment is enhanced and healthcare outcomes are improved through the use of printing technologies in pharmaceuticals. Beyond this thorough analysis, the study highlights potential and problems from several angles and comparative aspects between 3D and 4D printing.</div></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 6","pages":"Pages 804-813"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intelligent Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949866X24000686","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/25 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This overview examines the latest developments and applications of 3D and 4D printing in the health care and pharmaceutical field. The technique of creating a 3D object from a 3D model in the required size and shape is known as 3D printing. Whereas, 4D printing is the establishment of intricate three-dimensional formations that can change form in response to various external inputs. Applying 3D printing technology 3D printing, the healthcare industry has produced significant strides toward a patient-centred approach. The future of biomedical science and patient-centered care could be completely transformed by 3D printing with further advancements in research and development. 3D, 4D Technology used in printing is one of the most advanced industrial technologies available worldwide. The 3D and 4D printing pharmaceutical enterprises have completed the shift from centralised to distributed systems for the purpose of creating dosage forms. The goal of the study is to support the research goal of determining the degree to which patient-specific treatment is enhanced and healthcare outcomes are improved through the use of printing technologies in pharmaceuticals. Beyond this thorough analysis, the study highlights potential and problems from several angles and comparative aspects between 3D and 4D printing.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用 3D 和 4D 打印技术发展制药业
本概述探讨了三维和四维打印在医疗保健和制药领域的最新发展和应用。根据三维模型创建所需尺寸和形状的三维物体的技术被称为三维打印。而 4D 打印则是建立错综复杂的三维形态,可根据各种外部输入改变形态。应用三维打印技术三维打印技术,医疗保健行业在以患者为中心的方向上取得了长足进步。随着研发工作的进一步推进,3D 打印技术将彻底改变生物医学和以患者为中心的医疗服务的未来。用于打印的 3D 和 4D 技术是全球最先进的工业技术之一。3D和4D打印制药企业已经完成了从集中式系统到分布式系统的转变,目的是创造剂型。这项研究的目的是支持研究目标,即确定通过在制药中使用打印技术,在多大程度上加强了针对患者的治疗,改善了医疗效果。除了这一透彻的分析之外,该研究还从多个角度强调了三维打印和四维打印之间的潜力和问题,以及它们之间的比较方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Editorial Board A theoretical study of 8-hydroxy quinoline with fullerenes and carbon nanotubes as nano vectors for drug delivery DDI-LLM: Predicting unseen Drug–Drug Interactions using Large Language Models and molecular graphs Trophoblast-derived CD81 decreased eNOS expression in endothelial cell during preeclampsia development Innovative practices and reflections on the development of hospital-led co-constructed state key laboratories
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1